Researchers have made a groundbreaking discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with ...

The government has set aside £11.8bn to compensate victims of the infected blood scandal, after a public inquiry found the ...

Novo Nordisk today announced interim results from the phase 3 FRONTIER3 trial of 70 children (aged 1-11 years old) with haemophilia A with and without inhibitors. The trial initially assessed ...

Novo Nordisk’s haemophilia A therapy Mim8 stopped bleeding completely in 74.3% of children in a Phase III trial. The ...

Novo Nordisk has shared positive results from a late-stage study of its investigational haemophilia A therapy Mim8 in ...

Novo Nordisk today announced interim results from the phase 3 FRONTIER3 trial of 70 children (aged 1-11 years old) with haemophilia A with and without inhibitors. The trial initially assessed ...

Did you know that your blood type could play a much bigger role in your health than you thought? While cardiovascular risks ...

Gene therapy using modified blood stem cells helped five adults with severe hemophilia A reach therapeutic levels of clotting factor VIII.

while factor XIa activates it in the intrinsic coagulation pathway. Activated FIX, when combined with activated factor VIII, activates factor X. This leads to the transformation of prothrombin to ...

Hemophilia is a genetic disease that stems from the deficiency of a protein required for normal blood clotting – clotting factor VIII in hemophilia A or clotting factor IX in hemophilia B. As the ...